Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT00112294 · COMPLETED
Trial details
- NCT number
- NCT00112294
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-04-01
- Enrollment
- 755
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.